A股異動丨養老概念股高開 “十四五”綱要積極應對人口老齡化上升為國家戰略
格隆匯3月12日丨養老概念股高開,宜華健康以近漲停價開盤,雙箭股份高開2.6%。據新華社,國務院總理李克強在北京人民大會堂出席記者會時表示,中國的老齡人口已經有兩億六千萬,老齡產業也可以説是一個巨大的朝陽產業,它帶來了多樣化的需求。正因為中國市場的多層次、多樣化的需求,這樣一個廣大的市場也必然會給外國企業的產品、服務乃至於投資創造更多機會,因為我們的市場是開放的。iiMedia Research(艾媒諮詢)數據顯示, 2019年中國養老產業市場規模達6.91萬億元。艾媒諮詢分析師認為,在多方需求的驅動下,中國養老產業市場規模將會保持相對穩定的增長態勢,到2022年預計突破10萬億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.